Home > Methods

Methods

Nextstellis®: A new drug update 

  A new combined oral contraceptive was approved by the FDA (Nextstellis®) in April 2021.1 Nextstellis contains estetrol, an estrogen that can be manufactured from plants and that was originally derived naturally during pregnancy from the fetus liver, and drospirenone, a progestin found in other currently available contraceptives. Drospirenone has antiandrogenic and anti-mineralocorticoid activity.2 Estetrol differs…

Levonorgestrel Intrauterine Device for Emergency Contraception

A new research study evaluates levonorgestrel IUD for emergency contraception

Outreach Initiative to Expand Access to Depot Medroxyprogesterone Acetate (DMPA)

New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.

Meet Phexxi – A New Non-Hormonal Contraceptive Gel

About the Product Lactic acid, citric acid, and potassium bitartrate (Phexxi, Evofem Biosciences) is a prescription combination, non-hormonal contraceptive gel approved by the FDA in May 2020. The vaginal gel was found to be 86.3% effective with typical use when inserted up to 1 hour before vaginal intercourse.1 The gel acts as a contraceptive by…

Clinical Considerations for Contraception During COVID: Extended Duration of IUDs and Implants

During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.

Clinical Considerations for Contraception During COVID: Patient Self-Administration

During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.

Contraception for Your Transgender Patients

Terminology Navigating through a discussion about gender and sexuality with the many terms used today can be confusing. Here is a brief introduction to terminology regarding the multifaceted gender spectrum.1 Cisgender: Gender identity matches assigned gender at birth2 Transgender: Gender identity differs from assigned gender at birth2 Gender nonbinary/queer/fluid: Individuals do not identify with a…

Twirla: A New Contraceptive Patch

Twirla is a new contraceptive patch that was approved by the FDA earlier this month on February 14, 2020.